Spectrum Pharmaceuticals, Inc. product portfolio
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Product Patents

Patent Marking for Spectrum's Marketed Products

Product Patents
ZEVALIN (ibritumomab tiuxetan) injection for intravenous use 6,994,840, 7,229,620, 7,618,613, 7,608,241
FOLOTYN (pralatrexate injection) 6,028,071, 7,622,470, 8,299,078
MARQIBO (vinCRIStine sulfate LIPOSOME injection) 6,723,338, 7,247,316, 7,887,836
BELEODAQ (belinostat) for injection 6,888,027, 8,835,501
EVOMELA (melphalan) for Injection, 50 mg per vial 8,410,077, 9,200,088, 9,493,582

Back to top

Fusilev
BelinostatPoziotinib Qapzola Apaziquone Pralatraxate Rolontis